NEW YORK (GenomeWeb News) – In Nature Genetics, a team from Germany, Belgium, and Sweden described a de novo gain-of-function mutation in the voltage-gated sodium ion channel gene SCN11A that appears to produce a congenital condition characterized by the inability to feel pain, tissue damage, gastrointestinal ailments, and other features.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.